Sangamo uses its deep scientific expertise and proprietary zinc finger technology to create genomic cures for patients suffering from severe diseases for which today’s medicine can only offer symptom management at best.
Explore our pipeline| Priority Neurology Pipeline | ||||
| Indication | Technology | Preclinical | Phase 1/2 | Pivotal |
|---|---|---|---|---|
| Chronic Neuropathic Pain (Nav1.7) | ZF Genome Engineering | |||
| Prion Disease | ZF Genome Engineering | |||
| Neurology (undisclosed) | ZF Genome Engineering | |||
| Partnered Programs | ||||
| Indication | Technology | Preclinical | Phase 1/2 | Pivotal |
| Hemophilia A (Giroctocogene fitelparvovec) | Gene Therapy |
|
||
| Oncology | Cell Therapy | |||
| ALS/FTD | ZF Genome Engineering | |||
| Huntington’s Disease | ZF Genome Engineering | |||
| Other Pipeline | ||||
| Indication | Technology | Preclinical | Phase 1/2 | Pivotal |
| Fabry Disease | Gene Therapy | |||
| Renal Transplant (TX200; Auto) | Treg Cell Therapy | |||
| Inflammatory Bowel Disease | Treg Cell Therapy | |||
| Multiple Sclerosis | Treg Cell Therapy | |||